Detalhe da pesquisa
1.
Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states.
Cardiovasc Diabetol
; 23(1): 25, 2024 01 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38218814
2.
Antiphospholipid antibodies in patients with calcific aortic valve stenosis.
Rheumatology (Oxford)
; 62(3): 1187-1196, 2023 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35961031
3.
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE.
Cardiovasc Diabetol
; 22(1): 100, 2023 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37120538
4.
Empagliflozin improves insulin sensitivity in patients with recent acute coronary syndrome and newly detected dysglycaemia : Experiences from the randomized, controlled SOCOGAMI trial.
Cardiovasc Diabetol
; 22(1): 208, 2023 08 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37568149
5.
Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial.
Scand Cardiovasc J
; 57(1): 2166101, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36723445
6.
Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population.
J Card Fail
; 28(7): 1050-1062, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35550428
7.
Liver function markers predict cardiovascular and renal outcomes in the CANVAS Program.
Cardiovasc Diabetol
; 21(1): 127, 2022 07 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35787704
8.
Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort.
Cardiovasc Diabetol
; 21(1): 129, 2022 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35804351
9.
Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study.
Cardiovasc Diabetol
; 21(1): 195, 2022 09 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36151569
10.
Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANK.
Scand Cardiovasc J
; 56(1): 337-342, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35974709
11.
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Eur Heart J
; 42(26): 2565-2573, 2021 07 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33197271
12.
SGLT2 Inhibitors in Type 2 Diabetes Mellitus.
Heart Fail Clin
; 18(4): 551-559, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36216485
13.
Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys.
Cardiovasc Diabetol
; 20(1): 38, 2021 02 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33573665
14.
Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry.
Cardiovasc Drugs Ther
; 35(4): 801-808, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33068226
15.
Risk prediction in patients with diabetes: is SCORE 2D the perfect solution?
Eur Heart J
; 44(28): 2557-2559, 2023 07 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37288565
16.
Sodium-glucose transporter 2 inhibition and cardiovascular events in patients with diabetes: information from clinical trials and observational real-world data.
Clin Sci (Lond)
; 132(18): 2003-2012, 2018 09 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30232238
17.
N-terminal pro-B-type natriuretic peptide concentrations, testing and associations with worsening heart failure events.
ESC Heart Fail
; 11(2): 759-771, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38115625
18.
Universal screening for early detection of chronic autoimmune, metabolic and cardiovascular diseases in the general population using capillary blood (UNISCREEN): low-risk interventional, single-centre, pilot study protocol.
BMJ Open
; 14(3): e078983, 2024 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38448070
19.
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors.
Diabetes Care
; 47(2): 246-251, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38055929
20.
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries.
Eur Heart J Cardiovasc Pharmacother
; 2024 Apr 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38632048